Skip to main content
. 2020 Jul 30;34(11):2903–2913. doi: 10.1038/s41375-020-0996-5

Fig. 1. Subject disposition.

Fig. 1

The chart shows an overview of subjects who signed consent to participate in the study, their allocation into dose-escalation treatment cohorts, and reasons for their discontinuation from the study.